Aptevo Therapeutics Files Definitive Proxy Statement

TL;DR

APVO filed its proxy statement, standard procedure for shareholder votes.

AI Summary

Aptevo Therapeutics Inc. filed a definitive proxy statement (DEF 14A) on October 3, 2024, for its fiscal year ending December 31, 2024. The filing, related to the Securities Exchange Act of 1934, indicates no fee was required for this filing. The company is based in Seattle, WA, and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing is a standard regulatory requirement for public companies, providing shareholders with information necessary for upcoming votes, such as director elections or other corporate actions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.

Key Numbers

• 001-37746 — SEC File Number (Identifies the company's registration with the SEC.)

Key Players & Entities

• Aptevo Therapeutics Inc. (company) — Registrant
• 20241003 (date) — Filing Date
• 20241025 (date) — Period of Report
• 206-838-0500 (dollar_amount) — Business Phone

FAQ

Key Financial Figures

• $0.001 — our outstanding common stock, par value $0.001 per share (Common Stock), issuable upon
• $15,000 — g. We have agreed to pay Okapi a fee of $15,000. We will also reimburse Okapi for reaso
• $1.00 — ce of our Common Stock had closed below $1.00 per share, the minimum closing bid pric
• $0.33 — n Stock at a combined offering price of $0.33 per share and Common Warrants. Each sha

Filing Documents

• apvo-2024-def14a_-_sept_.htm (DEF 14A) — 333KB
• img169411897_0.jpg (GRAPHIC) — 924KB
• img169411897_1.jpg (GRAPHIC) — 650KB
• 0000950170-24-112395.txt ( ) — 2502KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 19 Householding of Proxy Materials 20 Other Matters 21 APPENDIX A A- 1 APTEVO THERAPEUTICS INC. 2401 4th Avenue, Suite 1050 Seattle, Washington 98121 PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS To be held on October 25, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING When is this Proxy Statement and accompanying proxy card (Proxy Card) first being mailed to stockholders? This Proxy Statement and Proxy Card are first being mailed on or about October 3, 2024 to stockholders of record entitled to vote at the Special Meeting. How do I attend the Special Meeting? In order to facilitate stockholder participation and save costs, the meeting will be held virtually on October 25, 2024 at 10 a.m. Pacific Time. There will not be a physical meeting . We have worked to offer the same participation opportunities as if you attended the Special Meeting in person and hope the online format will allow more stockholders to participate by removing any barriers caused by travel requirements. You may attend the Special Meeting online, including voting and submitting questions, at www.virtualshareholdermeeting.com/APVO2024SM by entering the 16-digit control number included on your Proxy Card. You should ensure you have a strong Internet connection wherever you intend to participate in the Special Meeting. We encourage you to access the Special Meeting before it begins. Online check-in will begin at 9:30 a.m. Pacific Time on the date of the Special Meeting. Our virtual meeting provider, Broadridge, facilitates stockholders’ opportunity to ask questions before and during the meeting. The Special Meeting site will provide stockholders with information regarding (i) time guidelines for their questions, rules around what types of questions are allowed, and rules for how questions and comments will be recognized and disclosed to meeting participants; and (ii)

View Full Filing

View this DEF 14A filing on SEC EDGAR